- Report
- July 2025
- 483 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 470 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 194 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 578 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- June 2025
- 141 Pages
Global
From €2657EUR$2,999USD£2,302GBP
- Report
- February 2025
- 134 Pages
Global
From €2657EUR$2,999USD£2,302GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1772EUR$2,000USD£1,535GBP
- Drug Pipelines
- April 2025
- 90 Pages
Global
From €1772EUR$2,000USD£1,535GBP
- Report
- February 2025
- 183 Pages
Global
From €3388EUR$3,825USD£2,936GBP
€3986EUR$4,500USD£3,454GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1772EUR$2,000USD£1,535GBP
- Clinical Trials
- April 2025
- 50 Pages
Global
From €1329EUR$1,500USD£1,151GBP
- Report
- June 2025
- 150 Pages
Global
From €2391EUR$2,699USD£2,072GBP
- Report
- June 2025
- 150 Pages
Global
From €2391EUR$2,699USD£2,072GBP
- Report
- June 2025
- 150 Pages
Global
From €2391EUR$2,699USD£2,072GBP
- Report
- June 2025
- 200 Pages
Global
From €2471EUR$2,789USD£2,141GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2471EUR$2,789USD£2,141GBP
- Report
- June 2025
- 150 Pages
Global
From €2391EUR$2,699USD£2,072GBP
- Report
- June 2025
- 400 Pages
Global
From €4384EUR$4,949USD£3,799GBP
- Report
- August 2024
- 200 Pages
Global
From €4384EUR$4,949USD£3,799GBP
- Report
- April 2025
- 182 Pages
Global
From €2215EUR$2,500USD£1,919GBP

The Ibuprofen market is a segment of the Over the Counter (OTC) Drugs industry. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It is available in a variety of forms, including tablets, capsules, gels, creams, and liquids. Ibuprofen is one of the most widely used OTC drugs, and is available in both generic and branded forms. It is often used to treat mild to moderate pain, as well as inflammation associated with arthritis and other conditions. Ibuprofen is also used to reduce fever and to treat menstrual cramps.
The Ibuprofen market is highly competitive, with a number of major players. Some of the leading companies in the market include Johnson & Johnson, Bayer, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more